NCT01981928View on ClinicalTrials.gov

A Clinical Trial to Investigate Safety and Tolerability of ASP7962 in Healthy Humans

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
SafetyTolerabilityPharmacokinetics of ASP7962
Interventions
DRUG

ASP7962

Oral

DRUG

Placebo

Oral

Trial Locations (1)

HA1 3UJ

Parexel Early Phase Clinical Unit London, London

All Listed Sponsors
lead

Astellas Pharma Europe B.V.

INDUSTRY

NCT01981928 - A Clinical Trial to Investigate Safety and Tolerability of ASP7962 in Healthy Humans | Biotech Hunter | Biotech Hunter